| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |